FDA
-
FDA Wants To Cut Inorganic Arsenic Levels In Infant Rice Cereal
-
Environmentalists Sue FDA Over Genetically Engineered Salmon
-
Gerber Recalls Batches Of Organic Fruit, Veggie Pouches Due To Possible Packaging Defect
-
BioMarin Drug Fails To Show Benefit In Inattention, Mood Complications Among Patients With PAH Deficiency
-
Cinqair Receives FDA Approval As Treatment For Severe Asthma
-
The FDA Cracks Down On Drug Abuse, Requires Warning Labels On Opioids
-
3-In-1 Test For Zika, Chikungunya and Dengue Gets Emergency FDA Approval
-
Video Of Man Urinating On Kellogg Factory Assembly Line Prompts FDA Investigation
-
Trial Of Genetically Engineered Mosquitoes To Fight Zika Gets Tentative FDA Approval
-
FDA Okays Pfizer's Lung Cancer Drug Xalkori For Expanded Use
-
FDA Settles With Drug Maker Amarin On Promotion Of Fish Oil Pill For Off-Label Use
-
FDA Wants Essure Contraceptive Implant To Come With Stronger Warning On Potential Risks
Most Popular
